Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study

Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate

(2014) Giuseppe Lopalco et al.   CLINICAL RHEUMATOLOGY

Successful Treatment of Tumor Necrosis Factor Receptor–Associated Periodic Syndrome With Canakinumab

(2013) Maria Giuseppina Brizi et al.   ANNALS OF INTERNAL MEDICINE

The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry

(2013) H J Lachmann et al.   ANNALS OF THE RHEUMATIC DISEASES

Review: Beyond the NLRP3 Inflammasome: Autoinflammatory Diseases Reach Adolescence

(2013) Marco Gattorno et al.   ARTHRITIS AND RHEUMATISM

Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

(2012) Nienke ter Haar et al.   ANNALS OF THE RHEUMATIC DISEASES

An International registry on Autoinflammatory diseases: the Eurofever experience

(2012) Natasa Toplak et al.   ANNALS OF THE RHEUMATIC DISEASES

Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS)

(2012) Tiziana Bachetti et al.   ANNALS OF THE RHEUMATIC DISEASES

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

(2012) Nicolino Ruperto et al.   NEW ENGLAND JOURNAL OF MEDICINE

Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome

(2011) N. Quillinan et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: A prospective, open-label, dose-escalation study

(2011) Ariel C. Bulua et al.   ARTHRITIS AND RHEUMATISM

Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis

(2010) L. Obici et al.   ANNALS OF THE RHEUMATIC DISEASES

Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes

(2010) Leigh D Church et al.   Expert Review of Clinical Immunology

Canakinumab

(2010) Eugen Dhimolea   mAbs

Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome

(2009) Belinda Nedjai et al.   ARTHRITIS AND RHEUMATISM

In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes

(2009) Helen J. Lachmann et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

(2009) Helen J. Lachmann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Persistent efficacy of anakinra in patients with tumor necrosis factor receptor–associated periodic syndrome

(2008) M. Gattorno et al.   ARTHRITIS AND RHEUMATISM